TOBLENT, created in 2008 (Japan), from 440 sister brands and 4958 competing brands. TOBLENT is a brand of Takeda Pharmaceutical, listed on the stock exchange of Francfort. The International Securities Identification Number (ISIN) of Takeda Pharmaceutical is JP3463000004. TOBLENT belongs to the Drug Manufacturers business sector.